INS and type 2 diabetes mellitus: Currently, the management of type 2 DM (T2DM) predominantly revolves around insulin therapy and a variety of oral antidiabetic agents, including α-glucosidase inhibitors, rosiglitazone, sulfonylureas, metformin, and thiazolidinediones (Kim et al., 2006; Lee et al., 2017).